| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net (loss) income | -21,778 | -11,660 |
| Depreciation and amortization | 733 | 542 |
| Stock-based compensation | 589 | 452 |
| Loss on disposal of property and equipment | -507 | - |
| Change in fair value of convertible notes payable | 1,891 | -1,617 |
| Change in fair value of warrant liabilities | 334 | 103 |
| Accounts receivable, net | -37 | -39 |
| Inventory, net | -1,053 | -756 |
| Prepaid expenses and other current assets | -252 | 10 |
| Accounts payable | -1,814 | -1,526 |
| Accrued liabilities | 4,802 | -335 |
| Other accrued liabilities | 2,119 | 1,379 |
| Operating lease liabilities | 15 | 10 |
| Other long-term liabilities | -3,616 | - |
| Net cash used in operating activities | -14,876 | -11,867 |
| Purchases of property and equipment | 865 | 345 |
| Net cash used in investing activities | -865 | -345 |
| Effect of foreign currency translation on cash and cash equivalents | -172 | -174 |
| Net change in cash and cash equivalents | -15,913 | -12,386 |
| Cash and cash equivalents at beginning of period | 20,586 | - |
| Cash and cash equivalents at end of period | 4,673 | - |
Adagio Medical Holdings, Inc. (ADGM)
Adagio Medical Holdings, Inc. (ADGM)